Epithelial Hypusination Regulates Helicobacter pylori-induced Gastric Inflammation

doi:10.21203/rs.3.rs-7906468/v1

Download PDF

Research Article

Epithelial Hypusination Regulates Helicobacter pylori-induced Gastric Inflammation

https://doi.org/10.21203/rs.3.rs-7906468/v1

This work is licensed under a CC BY 4.0 License

You are reading this latest preprint version

Hypusine is a unique amino acid synthesized on the eukaryotic initiation factor 5A (EIF5A) from the polyamine spermidine by deoxyhypusine synthase (DHPS). Hypusination of EIF5A plays a key role in translation. Here, we examined the contribution of the epithelial hypusination pathway to gastric inflammation induced by Helicobacter pylori. Immunohistochemical analyses revealed increased expression of DHPS and hypusinated EIF5A (EIF5A^Hyp) in the gastric mucosa of patients with H. pylori gastritis compared to uninfected individuals, notably within gastric epithelial cells (GECs) and immune infiltrates. Then, we created a mouse model with epithelial-specific deletion of Dhps (Dhps^Δepi) and confirmed the reduction of DHPS and EIF5A^Hyp in GECs. H. pylori-infected Dhps^Δepi mice exhibited an attenuation of gastric histologic inflammation scores compared with infected Dhps^fl/+ controls, without alteration in bacterial colonization levels. Quantitative proteomics of isolated GECs showed that Dhps deletion altered the expression of proteins involved in organismal injury, cancer, and gastrointestinal diseases in naïve mice. Upon H. pylori infection, inflammatory and immune response proteins, including signaling factors and immunoglobulin mediators, were less induced in Dhps^Δepi GECs, and pathways linked to tissue injury and inflammation were selectively downregulated. Together, these findings demonstrate that epithelial hypusination supports H. pylori-driven gastric inflammation without affecting bacterial persistence. Targeting DHPS-dependent EIF5A hypusination may thus represent a novel therapeutic strategy to limit H. pylori-associated mucosal injury and disease progression.

Infection

Gastritis

Polyamines

Hypusine

Proteome

The polyamine spermidine serves an essential role as the substrate for the synthesis of hypusine, a unique amino acid found only in the highly conserved eukaryotic protein eukaryotic translation initiation factor 5A (EIF5A) (Park et al. 1981). The hypusine modification is catalyzed by the sequential action of two enzymes, deoxyhypusine synthase (DHPS), the rate-limiting enzyme, which transfers the 4-aminobutyl moiety of the polyamine spermidine to the Lys50 residue of EIF5A (Joe et al. 1995; Park et al. 2006), and deoxyhypusine hydroxylase (DOHH), which hydroxylases the intermediate deoxyhypusine residue (Abbruzzese et al. 1986). This post-translational modification is essential for the function of EIF5A, as hypusinated EIF5A (EIF5A^Hyp) can bind mRNAs that contain a 5′-AAAUGU-3′ consensus sequence (Maier et al. 2010; Xu et al. 2004). EIF5A^Hyp can also alleviate ribosome stalling at polyproline repeats during translation elongation and at other non-polyproline motifs, such as peptides enriched in basic amino acids (Pelechano and Alepuz 2017; Schuller et al. 2017).

Hypusination has been implicated in regulating inflammatory responses, specifically in myeloid and T cells (Gobert et al. 2020; Puleston et al. 2021). We have reported that hypusination in myeloid cells supports the antimicrobial response of macrophages to pathogenic bacteria including Helicobacter pylori (Gobert et al. 2020), a bacteria that colonizes the human stomach and causes diseases ranging from non-atrophic gastritis to the precancerous lesions of multifocal atrophic gastritis, intestinal metaplasia (IM), dysplasia, and gastric adenocarcinoma (Correa 1988; Piazuelo et al. 2021). Notably, mice with a myeloid-specific deletion of Dhps exhibited increased bacterial burden and inflammation, implicating hypusination in host defense against pathogenic bacteria (Gobert et al. 2020). However, the effect of hypusination in gastric epithelial cells (GECs) on H. pylori pathogenesis remains unknown.

In this report, we showed that patients with H. pylori gastritis exhibit increased level of DHPS and hypusinated EIF5A. We then created mice with specific deletion of Dhps in intestinal epithelial cells including in the stomach to assess the role of hypusination in GECs in H. pylori pathogenesis. We found that these infected mice develop less gastritis, demonstrating that the activity of DHPS in GECs supports stomach inflammation. Further, the proteome of the GECs in Dhps-deficient mice is reshaped toward a less inflammatory and carcinogenic profile.

Ethics statement

Endoscopic gastric biopsies were obtained from patients at the Nashville Veterans Affairs Medical Center of the VA Tennessee Valley Healthcare System. Patients were undergoing esophagogastroduodenoscopy for clinically indicated reasons and provided informed consent for obtaining research biopsies under VA IRB protocol 1571167.

The mice were used under protocols V2000018 and V2300022 approved by the Vanderbilt University Medical Center Institutional Animal Care and Use Committee and the Research and Development Committee of the Veterans Affairs Tennessee Valley Healthcare System. Procedures followed institutional policies, AAALAC guidelines, the AVMA Guidelines on Euthanasia, NIH regulations regarding the Guide for the Care and Use of Laboratory Animals, and the United States Animal Welfare Act of 1996.

Bacteria

H. pylori PMSS1, a cagA⁺ strain with intact type IV secretion system function, was grown on Trypticase soy agar plates containing 10% sheep’s blood. Bacteria were harvested from the plates and grown overnight in Brucella broth containing 10% fetal bovine serum (FBS). This culture was resuspended in fresh Brucella broth-FBS and then collected at the exponential phase to infect the mice.

Mice and infections

We used Foxa3-cre mice that we crossed with Dhps^fl/fl mice to obtain C57BL/6 Dhps^fl/+;Foxa3^+/+ (Dhps^fl/+) and Dhps^fl/+;Foxa3^cre/+ (Dhps^Δepi) mice. Note that Dhps^fl/fl; Foxa3^cre/+ mice were embryonically lethal or only survived a few weeks out of utero. Mice were housed in a pathogen-free facility, with ventilated cage racks and were on a 12 h light-dark cycle. Male and female mice between 8 and 12 weeks were used for all studies. Animals were infected by oral gavage with 10⁹ colony forming units (CFU) of H. pylori PMSS1 in 200 µL Brucella broth, two times, on days 0 and 2. The control mice were gavaged with only broth on both days. Eight weeks after the first infection, mice were euthanized and stomachs were harvested. Colonization was determined in all infected mice by counting the CFUs cultured after plating serial dilutions of homogenized gastric tissues (Latour et al. 2022; McNamara et al. 2025; Sierra et al. 2020).

Histopathology

Human biopsies from the gastric antrum and corpus, and longitudinal strips of murine stomach tissue including the corpus and antrum, were fixed in 10% neutral buffered formalin, paraffin-embedded, and stained with hematoxylin and eosin (H&E). Biopsies were scored as reported (Latour et al. 2022; McNamara et al. 2025; Sierra et al. 2020). Histology was scored by our gastrointestinal pathologist (M.B.P.) who was blinded to the experimental groups. H. pylori infection of patient tissues was confirmed by culture of gastric biopsies as described above for the mouse tissues.

Epithelial cell isolation

Stomachs were removed from Dhps^fl/+ and Dhps^Δepi animals and incubated in a solution of cold 0.5 mM DTT and 3 mM EDTA for 30 min on ice. After incubation, the tissues were placed in 3 mM EDTA and vigorously shaken to release gastric glands. The cell suspension was poured over a 70 µm Strainer (Falcon) and the resulting isolated GECs were pelleted through centrifugation at 1500 rpm for 10 min at 4 °C.

Proteomics analysis

Isolated epithelial cells were lysed in 50 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 2 mM EDTA, and 1% SDS; protein concentration was measured by the BCA Protein Assay (Pierce) and samples from the same group were pooled. Protein extracts were reduced with 10 mM TCEP (tris(2-carboxyethyl)phosphine), alkylated with 20 mM iodoacetamide, and protein samples were prepared by S-Trap™ (ProtiFi) digestion with trypsin (1:10) similar to methods described in Howard et al (Howard et al. 2024). TMT-based quantitative proteomics was performed as described (Latour et al. 2022). Labeled peptides (5 µg per sample) were combined, fractionated using high pH reversed phase fractionation, and elution steps were performed with 10%, 12.5%, 15%, 17.5%, 20%, 22.5%, 25%, and 60% acetonitrile with 0.1% triethylamine. Fractions were dried and reconstituted in 0.2% formic acid for LC-MS/MS analysis. Peptides were gradient-eluted at a flow rate of 350 nl/min, using varied reverse phase gradients over 90 min. For fraction 1, peptides were analyzed with the following gradient: 5–18% B in 75 min, 18–50% B in 6 min, 50–70% B in 3 min, 70 − 2% B in 1 min, 2% B for 5 min. For fractions 2–4, the first 2 steps of the gradient were adjusted to 5–25% B in 75 min and 25–50% B in 6 min, with the subsequent three steps identical to fraction 1. For fraction 5, the gradient included 2–8% B in 0.5 min, 8–30% B in 74.5 min, 30–50% B in 6 min, 50–70% B in 2 min, followed by the same final two steps. For fraction 6, the gradient included 2–8% B in 2 min, 8–30% B in 73 min, 30–50% B in 7 min, 50–70%B in 1 min, followed by the same final two steps. For fraction 7–8, the gradient included 5–45% B in 75 min, 45–90% B in 8 min, 90% B for 1 min, 90 − 2% B in 1 min, and 2% B for 5 min. Peptides were analyzed using a data-dependent acquisition method on an Orbitrap Exploris 240 mass spectrometer (Thermo Scientific), equipped with a nanoelectrospray ionization source. The instrument method consisted of MS1, followed by up to 20 MS/MS scans, with an automatic gain control target of 2x10⁵. Higher-energy collisional dissociation was set to 35 nce and dynamic exclusion (15 sec) was enabled. Data were searched in Proteome Discoverer 2.2 (Thermo Scientific) using SequestHT for database searching against a mouse database created from the UniProtKB database. Search parameters and quantitative analysis was performed as reported (Latour et al. 2022).

The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al. 2025) partner repository with the dataset identifier PXD069622

Ingenuity pathway analysis (IPA) software (QIAGEN) was used for the functional interpretation of differential expression results obtained from the proteomic analyses. The pathways related to Diseases and Functions were generated.

Western blot analysis

Proteins were extracted from isolated GECs as reported (Latour et al. 2022) and concentrations were determined using the BCA Protein Assay (Pierce). Western blots were performed using 10 µg protein per lane using a rabbit polyclonal anti-DHPS antibody (Ab; Abcam, Cat#ab202133; 1:5000), a rabbit polyclonal anti-EIF5A^Hyp Ab (Millipore, Cat#ABS1064-I; 1:8000), or a mouse monoclonal anti-b-actin Ab (MilliporeSigma, Cat#A5316; 1:10000). The Peroxidase AffiniPure® Goat Anti-Rabbit IgG (H + L) (Jackson ImmunoResearch, Cat#111-035-003; 1:5000) or the goat anti-mouse IgG, HRP-labeled (Jackson ImmunoResearch, Cat#115-035-003; 1:5000) were the used as secondary Abs.

Immunostaining

Immunofluorescence was performed on human gastric biopsies and murine gastric tissues. Sections were deparaffinized and incubated at room temperature with 3% hydrogen peroxide in phosphate-buffered saline to block endogenous peroxidase. Tissues were then blocked for 1 h in Protein Block, Serum-Free (Dako, Cat#X0909). Slides were sequentially incubated with a rabbit polyclonal anti-DHPS Ab (Proteintech, Cat#11184-1-AP; 1:1000) or a rabbit anti-EIF5A^Hyp Ab (MilliporeSigma Cat#ABS1064; 1:2000) overnight at 4°C and with a donkey anti-Rabbit IgG (H + L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor™ Plus 488 (ThermoFisher Scientific, Cat#A32790; 1:700) 45 min at room temperature. Slides were mounted with VECTASHIELD HardSet™ Antifade Mounting Medium with DAPI (Vector Laboratories, Cat#H-1500-10) and visualized using a Nikon E800 microscope and a SPOT Imaging CMOS camera.

Statistics

Prism 10.6.0 (GraphPad Inc.) was used for figure design and statistical analysis. All the data are expressed as mean ± SEM. Data that were not normally distributed according to the D’Agostino & Pearson normality test were log transformed. Student’s t test was used to determine significant differences between two groups, whereas a one-way ANOVA followed by a Tukey’s test or Šídák’s test was used for multiple groups.

Increased levels of DHPS and EIF5A^Hyp in H. pylori-infected patients

Using immunostaining, we evidenced that that the level of DHPS and hypusinated EIF5A were increased overall in the gastric mucosa of endoscopic biopsies from patients with H. pylori gastritis compared to individuals without infection (Fig. 1). Of importance, the staining was abundant in GECs in H. pylori-infected patients but also present in the immune infiltrates, as we reported (Gobert et al. 2020).

Deletion of epithelial hypusination reduces the inflammatory response to H. pylori

To investigate the role of hypusination in epithelial cells during H. pylori infection we utilized a genetic approach by generating C57BL/6 animals with a gastric epithelial-specific knockout of Dhps. First, we verified by immunoblots and densitometry that Dhps^Δepi mice exhibited reduced expression of DHPS and EIF5A^Hyp levels in the gastric epithelium compared to Dhps^fl/+ control mice (Fig. 2A and 2B).

Then, we infected Dhps^fl/+ and Dhps^Δepi mice with H. pylori PMSS1 for 8 weeks. We confirmed by immunofluorescence that DHPS and EIF5A^Hyp were less expressed in GECs from naive Dhps^Δepi mice (Fig. 3A). Upon infection, the levels of DHPS and EIF5A^Hyp were increased in GECs and immune infiltrates of Dhps^fl/+ mice compared to uninfected animals (Fig. 3A); there was markedly less staining in the GECs of Dhps^Δepi mice, whereas immune cells were still positive for DHPS (Fig. 3A).

All 30 Dhps^Δepi mice were colonized and only 1 of the 21 Dhps^fl/+ mice was not colonized and was thus removed from the analysis. We observed no difference in gastric bacterial burden between both genotypes (Fig. 3B). An inflammatory infiltrate and mild foveolar hyperplasia were mainly observed at the antrocorporal transitional mucosa of H. pylori-infected Dhps^fl/+ mice (Fig. 3C). These parameters were less observed in the stomach of infected Dhps^Δepi mice (Fig. 3C). Using a comprehensive score, we found increased inflammation in both genotypes compared to uninfected animals, but also significantly less inflammation in the gastric tissue of infected Dhps^Δepi mice compared to the infected Dhps^+/fl mice (Fig. 3D).

Proteome of H. pylori-infected animals with Dhps deficiency

To determine the role of the hypusination pathway during H. pylori-mediated inflammation, we performed TMT proteomics on isolated GECs from uninfected and infected Dhps^fl/+and Dhps^Δepi mice.

First, we analyzed the proteome in GECs from naïve mice. There were 79 proteins significantly induced by the specific Dhps deletion in epithelial cells (Supplementary Table S1). These proteins were signaling molecules, such as cyclin-dependent kinase 1 (CDK1) or Src substrate cortactin (SRC8), the superoxide dismutase SODM, and numerous heterogeneous nuclear ribonucleoproteins (ROA1/A2/A3/AA), which are RNA-binding proteins playing critical roles in multiple cellular processes such as DNA repair and regulation of gene expression (Fig. 4A and Supplementary Table S1). We also found 183 proteins downregulated in GECs from Dhps^Δepi mice. Among them we found numerous ribosomal proteins (e.g., RM24, RS4X, RT33), as expected, different cytochromes P450 (e.g. CP3AB, CP2E1, CP1A2), and one glutathione-S-transferase (MGST1) (Fig. 4A and Supplementary Table S1). The changes in the level of these proteins in GECs were overall associated with a lessening of the pathways associated with organismal injury, cancer, and gastrointestinal diseases in Dhps^Δepi mice (Fig. 4B and Supplementary Table S2); pathways associated with cell movement were mainly induced in Dhps^Δepi mice (Fig. 4B and Supplementary Table S2).

We identified 110 and 174 proteins significantly induced by H. pylori infection in the GECs from the stomach tissues from Dhps^fl/+ and Dhps^Δepi mice, respectively. Among them, 37 were in common to both genotypes (Fig. 5A). These included mediators of adaptive immunity (IGHA, HB2A/2I, HG2A, and TGTP2), and regulators of the innate immune response, such as DOXA2, I23O1, and STAT1 (Fig. 5B and Supplementary Table S1). However overall, the level of expression of these proteins in H. pylori-infected Dhps^Δepi mice was lower compared to infected Dhps^fl/+animals (Fig. 5B). Moreover, there were 170 proteins significantly downregulated in GECs from Dhps^fl/+ mice with infection (Fig. 5A), whereas only 61 proteins were less expressed in infected Dhps^Δepi GECs (Fig. 5A); only 18 proteins were similar in both genotypes (Fig. 5A). The proteins downregulated by H. pylori infection in Dhps^fl/+animals included numerous cytochromes, e.g., CP2F, CP2E1, CP3AB, CP2DA, and CP240, which are known to be downregulated during infection and inflammation, TFF1, the stabilizer of the mucous gel overlying the gastrointestinal mucosa that provides a physical barrier against bacteria, and the marker of M2/Mreg macrophages, ARGI1 (Fig. 5C and Supplementary Table S1); most of these effectors were less altered in infected Dhps^Δepi mice (Fig. 5C and Supplementary Table S1).

When we analyzed the functional clusters corresponding to the proteins differentially expressed between infected Dhps^Δepi versus infected Dhps^fl/+ mice (see Supplementary Table S1), we evidenced that numerous pathways related to infections were significantly upregulated, whereas the biological processes related to inflammation were mainly downregulated (Fig. 5D and Supplementary Table S3).

DHPS is the rate-limiting enzyme for the synthesis of hypusine on EIF5A, thus controlling its activation and the translation of specific proteins. In this report, we found that DHPS was induced in GECs of mice infected by the gastric pathogen H. pylori; consequently, the level of EIF5A^Hyp was also increased in the gastric epithelium. Interestingly, when we specifically knocked-down DHPS in intestinal epithelial cells, we found less H. pylori-induced gastritis in the stomach, suggesting that hypusination in GECs supports inflammation. Our proteomic investigation in isolated GECs from the mice confirmed that the reduction of hypusination was associated with reduced expression of proteins involved in pathophysiological processes in both naïve and infected mice. Lastly, the increased level of hypusination in GECs from patients with H. pylori gastritis underlines the clinical relevance of our findings and highlights DHPS as a potential target to reduce the development of the diseases associated with H. pylori infection.

The homozygous deletion of the Dhps gene results in embryonic lethality (Nishimura et al. 2012) and biallelic variants in the DHPS gene in humans have been linked to a neurodevelopmental disorder (Ganapathi et al. 2019), evidencing that DHPS activity is globally essential for embryogenesis and homeostasis, and therefore constitutively expressed. Notably, this gene can be induced, as we reported increased DHPS levels in macrophages infected with pathogenic bacteria, including H. pylori (Gobert et al. 2020), in human colonic epithelial cells (CECs) infected in vitro with enteropathogenic Escherichia coli, and in the colon of mice infected with Citrobacter rodentium, a bacterial pathogen of the colon that induces colitis in mice (Gobert et al. 2024). Moreover, the expression of DHPS is also increased in adipose tissue macrophages of obese mice and in bone marrow-derived macrophages from C57BL/6J mice stimulated toward an M1 phenotype with LPS + IFN-g (Anderson-Baucum et al. 2021). Similarly, we found increased expression of DHPS in GECs from H. pylori-infected humans and mice; this was associated with an enhanced level of EIF5A^Hyp, as expected.

We previously reported that the specific deletion of DHPS in myeloid cells using a Lyz2-Cre driver yields an increased colonization of the colon by the rodent pathogen C. rodentium and of the stomach by H. pylori (Gobert et al. 2020). This observation led us to propose that hypusination supports macrophage activity, which was consistent with the loss of expression of innate proteins with antimicrobial functions in infected Dhps^Dmye mice (Gobert et al. 2020). Moreover, we have reported that mice with knock-down of Dhps in intestinal epithelial cells also exhibit increased C. rodentium burden in the colon (Gobert et al. 2024), although the hypusine-dependent proteome of macrophages differed from that of CECs in infected mice (Gobert et al. 2020; Gobert et al. 2024). Herein, we found that Dhps deletion in the stomach has no impact on gastric colonization by H. pylori, demonstrating that hypusination in GECs does not play a major role in the antimicrobial effect of the gastric mucosa and the cell-specificity of DHPS activity. Moreover, we found reduced inflammation and histological damage in H. pylori-infected Dhps^∆epi mice. In contrast, mice with specific Dhps deletion in intestinal epithelial cells exhibited spontaneous colitis and inflammation of the small intestine, increased susceptibility to dextran sulfate sodium-induced and C. rodentium-mediated colitis, and exacerbated tumorigenesis in response to the carcinogen azoxymethane (Gobert et al. 2024; Gobert et al. 2023) compared to Dhps^fl/fl animals. In this context, we propose that the role of hypusination in epithelial cells throughout the gastrointestinal tract is clearly organ specific, being protective in the colon and deleterious in the stomach. The reason behind this discrepancy is likely related to the nature of the transcriptomes of GECs and CECs that are drastically different due to their distinct physiological functions and microenvironments; therefore, the proteins regulated by hypusination in these organs are different, as we have observed in our previous report (Gobert et al. 2023) and in the present study.

DHPS activity is also controlled by the availability of its substrate spermidine (Gobert et al. 2023). The concentration of this polyamine is regulated by the enzyme spermine oxidase (SMOX) in the gastrointestinal tract (Gobert et al. 2022). Interestingly, we reported that deletion of Smox in C57BL6 mice and in cancer-prone transgenic FVB/N mice overexpressing the human gastrin gene reduces the development of gastritis and gastric carcinoma, respectively (McNamara et al. 2025; Sierra et al. 2020), demonstrating that SMOX activity mediates H. pylori pathogenesis. Although we attributed the deleterious effects of SMOX on the synthesis of the monocarbonyl electrophile acrolein in the stomach (McNamara et al. 2025), it is also possible that DHPS activity can be enhanced by the generation of spermidine by SMOX. Thus, collectively these data indicate that the spermidine/hypusine pathway is a critical mediator of H. pylori pathogenesis.

The development of precancerous lesions in H. pylori-infected patients often occurs in the context of chronic gastritis (Correa 1988; Piazuelo et al. 2021). Moreover, eradication of H. pylori does not necessarily reduce cancer risk once precancerous lesions are present (Ma et al. 2012; Mera et al. 2005). Therefore, the inhibition of hypusination in the stomach might represent a therapeutic approach to dampen gastritis, but also a preventive strategy to reduce the risk of gastric cancer development. Further, it has been reported that hypusination supports the growth and proliferation of various established cancer cell lines (Bandino et al. 2014; Fang et al. 2018; Zhao et al. 2025), including from the gastrointestinal tract (Coni et al. 2020). In this context, the study of the role of the spermidine/hypusine pathway on gastric cancer cells is warranted and is underway in our laboratory.

Competing interest:

The authors disclose no conflicts.

Grant Support

This study was funded by NIH grants R01DK128200, P01CA116087, and P01CA028842 (KTW); Veterans Affairs Merit Review grants I01CX002171 and I01CX002473 (KTW) and I01BX004366 (LAC); Department of Defense Peer Reviewed Cancer Research Program Impact Award W81XWH-21-1-0617 (KTW); a gift from CURE for IBD (KTW); the Thomas F Frist Sr. Endowment (KTW); and the Vanderbilt Center for Mucosal Inflammation and Cancer (KTW). KMM was supported by T32CA009592 and F31CA278330. The Tissue Morphology Core (MBP) of the Vanderbilt Digestive Disease Research Center is supported by P30DK058404, and the proteomics studies were supported by the Proteomics and Metabolomics Core of P01CA116087 and the Mass Spectrometry Cores of P30DK058404 and the Vanderbilt Ingram Cancer Center supported by NIH grant P30CA068485.

Author Contribution

Conceptualization, A.P.G., K.M.M., and K.T.W.; Formal Analysis, K.L.R.; Investigation, K.M.M., C.V.H., M.A., D.P.B., A.G.D., P.P., R.N.T., K.S.C., L.A.C., M.B.P., and K.T.W.; Writing – Original Draft, A.P.G. and K.M.M.; Writing – Review & Editing, A.P.G. and K.T.W.; Visualization, A.P.G. and K.M.M.; Supervision, A.P.G. and K.T.W.; Funding Acquisition, A.P.G. and K.T.W.

Data Availability

The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al. 2025) partner repository with the dataset identifier PXD069622.

Abbruzzese A, Park MH, Folk JE (1986) Deoxyhypusine hydroxylase from rat testis. Partial purification and characterization. J Biol Chem 261 (7):3085-3089
Anderson-Baucum E, Pineros AR, Kulkarni A, Webb-Robertson BJ, Maier B, Anderson RM, Wu W, Tersey SA, Mastracci TL, Casimiro I, Scheuner D, Metz TO, Nakayasu ES, Evans-Molina C, Mirmira RG (2021) Deoxyhypusine synthase promotes a pro-inflammatory macrophage phenotype. Cell Metab 33 (9):1883-1893 e1887
Bandino A, Geerts D, Koster J, Bachmann AS (2014) Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21/RB-mediated inhibition of tumor cell growth and dhps expression correlates with poor prognosis in neuroblastoma patients. Cell Oncol (Dordr) 37 (6):387-398
Coni S, Serrao SM, Yurtsever ZN, Di Magno L, Bordone R, Bertani C, Licursi V, Ianniello Z, Infante P, Moretti M, Petroni M, Guerrieri F, Fatica A, Macone A, De Smaele E, Di Marcotullio L, Giannini G, Maroder M, Agostinelli E, Canettieri G (2020) Blockade of EIF5A hypusination limits colorectal cancer growth by inhibiting MYC elongation. Cell Death Dis 11 (12):1045
Correa P (1988) A human model of gastric carcinogenesis. Cancer Res 48 (13):3554-3560
Fang L, Gao L, Xie L, Xiao G (2018) GC7 enhances cisplatin sensitivity via STAT3 signaling pathway inhibition and EIF5A2 inactivation in mesenchymal phenotype oral cancer cells. Oncol Rep 39 (3):1283-1291
Ganapathi M, Padgett LR, Yamada K, Devinsky O, Willaert R, Person R, Au PB, Tagoe J, McDonald M, Karlowicz D, Wolf B, Lee J, Shen Y, Okur V, Deng L, LeDuc CA, Wang J, Hanner A, Mirmira RG, Park MH, Mastracci TL, Chung WK (2019) Recessive rare variants in deoxyhypusine synthase, an enzyme involved in the synthesis of hypusine, are associated with a neurodevelopmental disorder. Am J Hum Genet 104 (2):287-298
Gobert AP, Finley JL, Latour YL, Asim M, Smith TM, Verriere TG, Barry DP, Allaman MM, Delagado AG, Rose KL, Calcutt MW, Schey KL, Sierra JC, Piazuelo MB, Mirmira RG, Wilson KT (2020) Hypusination orchestrates the antimicrobial response of macrophages. Cell Rep 33 (11):108510
Gobert AP, Latour YL, Asim M, Barry DP, Allaman MM, Finley JL, Smith TM, McNamara KM, Singh K, Sierra JC, Delgado AG, Luis PB, Schneider C, Washington MK, Piazuelo MB, Zhao S, Coburn LA, Wilson KT (2022) Protective role of spermidine in colitis and colon carcinogenesis. Gastroenterology 162 (3):813-827
Gobert AP, Smith TM, Latour YL, Asim M, Barry DP, Allaman MM, Williams KJ, McNamara KM, Delgado AG, Short SP, Mirmira RG, Rose KL, Schey KL, Zagol-Ikapitte I, Coleman JS, Boutaud O, Zhao S, Piazuelo MB, Washington MK, Coburn LA, Wilson KT (2023) Hypusination maintains intestinal homeostasis and prevents colitis and carcinogenesis by enhancing aldehyde detoxification. Gastroenterology 165 (3):656-669
Gobert AP, Hawkins CV, Williams KJ, Snyder LA, Barry DP, Asim M, Allaman MM, McNamara KM, Delgado AG, Wang Y, Zhao S, Rose KL, Piazuelo MB, Wilson KT (2024) Hypusination in intestinal epithelial cells protects mice from infectious colitis. Gut Microbes 16 (1):2438828
Howard GC, Wang J, Rose KL, Jones C, Patel P, Tsui T, Florian AC, Vlach L, Lorey SL, Grieb BC, Smith BN, Slota MJ, Reynolds EM, Goswami S, Savona MR, Mason FM, Lee T, Fesik S, Liu Q, Tansey WP (2024) Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition. Elife 12
Joe YA, Wolff EC, Park MH (1995) Cloning and expression of human deoxyhypusine synthase cDNA. Structure-function studies with the recombinant enzyme and mutant proteins. J Biol Chem 270 (38):22386-22392
Latour YL, Sierra JC, Finley JL, Asim M, Barry DP, Allaman MM, Smith TM, McNamara KM, Luis PB, Schneider C, Jacobse J, Goettel JA, Calcutt MW, Rose KL, Schey KL, Milne GL, Delgado AG, Piazuelo MB, Paul BD, Snyder SH, Gobert AP, Wilson KT (2022) Cystathionine gamma-lyase exacerbates Helicobacter pylori immunopathogenesis by promoting macrophage metabolic remodeling and activation. JCI Insight 7 (12):e155338
Ma JL, Zhang L, Brown LM, Li JY, Shen L, Pan KF, Liu WD, Hu Y, Han ZX, Crystal-Mansour S, Pee D, Blot WJ, Fraumeni JF, Jr., You WC, Gail MH (2012) Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 104 (6):488-492
Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, Chakrabarti SK, Nunemaker CS, Stull ND, Taylor CA, Thompson JE, Dondero RS, Lewis EC, Dinarello CA, Nadler JL, Mirmira RG (2010) The unique hypusine modification of EIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest 120 (6):2156-2170
McNamara KM, Sierra JC, Latour YL, Hawkins CV, Asim M, Williams KJ, Barry DP, Allaman MM, Zagol-Ikapitte I, Luis PB, Schneider C, Delgado AG, Piazuelo MB, Tyree RN, Carson KS, Choksi YA, Coburn LA, Gobert AP, Wilson KT (2025) Spermine oxidase promotes Helicobacter pylori-mediated gastric carcinogenesis through acrolein production. Oncogene 44 (5):296-306
Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P (2005) Long term follow up of patients treated for Helicobacter pylori infection. Gut 54 (11):1536-1540
Nishimura K, Lee SB, Park JH, Park MH (2012) Essential role of EIF5A-1 and deoxyhypusine synthase in mouse embryonic development. Amino Acids 42 (2-3):703-710
Park JH, Aravind L, Wolff EC, Kaevel J, Kim YS, Park MH (2006) Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: A heat-repeat-containing metalloenzyme. Proc Natl Acad Sci U S A 103 (1):51-56
Park MH, Cooper HL, Folk JE (1981) Identification of hypusine, an unusual amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic precursor. Proc Natl Acad Sci U S A 78 (5):2869-2873
Pelechano V, Alepuz P (2017) Eif5a facilitates translation termination globally and promotes the elongation of many non polyproline-specific tripeptide sequences. Nucleic Acids Res 45 (12):7326-7338
Perez-Riverol Y, Bandla C, Kundu DJ, Kamatchinathan S, Bai J, Hewapathirana S, John NS, Prakash A, Walzer M, Wang S, Vizcaino JA (2025) The pride database at 20 years: 2025 update. Nucleic Acids Res 53 (D1):D543-D553
Piazuelo MB, Bravo LE, Mera RM, Camargo MC, Bravo JC, Delgado AG, Washington MK, Rosero A, Garcia LS, Realpe JL, Cifuentes SP, Morgan DR, Peek RM, Jr., Correa P, Wilson KT (2021) The colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions. Gastroenterology 160 (4):1106-1117
Puleston DJ, Baixauli F, Sanin DE, Edwards-Hicks J, Villa M, Kabat AM, Kaminski MM, Stanckzak M, Weiss HJ, Grzes KM, Piletic K, Field CS, Corrado M, Haessler F, Wang C, Musa Y, Schimmelpfennig L, Flachsmann L, Mittler G, Yosef N, Kuchroo VK, Buescher JM, Balabanov S, Pearce EJ, Green DR, Pearce EL (2021) Polyamine metabolism is a central determinant of helper t cell lineage fidelity. Cell 184 (16):4186-4202
Schuller AP, Wu CC, Dever TE, Buskirk AR, Green R (2017) EIF5A functions globally in translation elongation and termination. Mol Cell 66 (2):194-205
Sierra JC, Piazuelo MB, Luis PB, Barry DP, Allaman MM, Asim M, Sebrell TA, Finley JL, Rose KL, Hill S, Holshouser SL, Casero RA, Cleveland JL, Woster PM, Schey KL, Bimczok D, Schneider C, Gobert AP, Wilson KT (2020) Spermine oxidase mediates Helicobacter pylori-induced gastric inflammation, DNA damage, and carcinogenic signaling. Oncogene 39 (22):4465-4474
Xu A, Jao DL, Chen KY (2004) Identification of mRNA that binds to eukaryotic initiation factor 5a by affinity co-purification and differential display. Biochem J 384 (Pt 3):585-590
Zhao G, Zhao X, Liu Z, Wang B, Dong P, Watari H, Pfeffer LM, Tigyi G, Zhang W, Yue J (2025) Knockout or inhibition of dhps suppresses ovarian tumor growth and metastasis by attenuating the tgfbeta pathway. Sci Rep 15 (1):917

No competing interests reported.

Download PDF

Editorial decision: Revision requested
10 Dec, 2025
Reviews received at journal
10 Dec, 2025
Reviews received at journal
09 Dec, 2025
Reviewers agreed at journal
20 Nov, 2025
Reviews received at journal
19 Nov, 2025
Reviewers agreed at journal
19 Nov, 2025
Reviewers agreed at journal
10 Nov, 2025
Reviewers invited by journal
23 Oct, 2025
Editor assigned by journal
21 Oct, 2025
Submission checks completed at journal
21 Oct, 2025
First submitted to journal
20 Oct, 2025

You are reading this latest preprint version

Epithelial Hypusination Regulates Helicobacter pylori-induced Gastric Inflammation

Status:

Version 1

Abstract

Figures

Introduction

Materials and methods

Ethics statement

Bacteria

Mice and infections

Histopathology

Epithelial cell isolation

Proteomics analysis

Western blot analysis

Immunostaining

Statistics

Results

Discussion

Declarations

Competing interest:

Grant Support

Author Contribution

Data Availability

References

Additional Declarations

Supplementary Files

Status:

Version 1